Join to view full profile
55 Wade AveSpring Grove Hospital CenterCatonsville, MD 21228
Phone+1 410-402-6000
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Brave, MD is a hematologist in Catonsville, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 1993 - 1995
Sinai Hospital of BaltimoreResidency, Internal Medicine, 1992 - 1993
MedStar Franklin Square Medical CenterResidency, Internal Medicine, 1987 - 1989
Johns Hopkins University/Bayview Medical CenterInternship, Internal Medicine, 1986 - 1987
Drexel University College of MedicineClass of 1986
Certifications & Licensure
MD State Medical License 1987 - 2026
Publications & Presentations
PubMed
- 9 citationsSurvival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration po...Jaleh Fallah, Lijun Zhang, Anup K. Amatya, Yutao Gong, Bellinda L. King-Kallimanis
The Lancet. Oncology. 2021-09-01 - 19 citationsArterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and ...Connie Cheng, Michelle Nadeau Nguyen, Afrouz Nayernama, S. Christopher Jones, Michael Brave
Vascular Medicine. 2021-04-12 - 19 citationsAn FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer.Michael Brave, Chana Weinstock, Jamie R. Brewer, Dow-Chung Chi, Daniel L. Suzman
Clinical Cancer Research. 2020-01-01
Press Mentions
- NEWSMD Special Report: The Risks of Police RestraintMarch 6th, 2021
